Browse > Article
http://dx.doi.org/10.4062/biomolther.2015.024

Anti-Proliferative Effect of Naringenin through p38-Dependent Downregulation of Cyclin D1 in Human Colorectal Cancer Cells  

Song, Hun Min (Department of Bioresource Sciences, Andong National University)
Park, Gwang Hun (Department of Bioresource Sciences, Andong National University)
Eo, Hyun Ji (Department of Bioresource Sciences, Andong National University)
Lee, Jin Wook (Department of Bioresource Sciences, Andong National University)
Kim, Mi Kyoung (Department of Bioresource Sciences, Andong National University)
Lee, Jeong Rak (Gyeongbuk Institute for Bio-industry)
Lee, Man Hyo (Gyeongbuk Institute for Bio-industry)
Koo, Jin Suk (Department of Bioresource Sciences, Andong National University)
Jeong, Jin Boo (Department of Bioresource Sciences, Andong National University)
Publication Information
Biomolecules & Therapeutics / v.23, no.4, 2015 , pp. 339-344 More about this Journal
Abstract
Naringenin (NAR) as one of the flavonoids observed in grapefruit has been reported to exhibit an anti-cancer activity. However, more detailed mechanism by which NAR exerts anti-cancer properties still remains unanswered. Thus, in this study, we have shown that NAR down-regulates the level of cyclin D1 in human colorectal cancer cell lines, HCT116 and SW480. NAR inhibited the cell proliferation in HCT116 and SW480 cells and decreased the level of cyclin D1 protein. Inhibition of proteasomal degradation by MG132 blocked NAR-mediated cyclin D1 downregulation and the half-life of cyclin D1 was decreased in the cells treated with NAR. In addition, NAR increased the phosphorylation of cyclin D1 at threonine-286 and a point mutation of threonine-286 to alanine blocked cyclin D1 downregulation by NAR. p38 inactivation attenuated cyclin D1 downregulation by NAR. From these results, we suggest that NAR-mediated cyclin D1 downregulation may result from proteasomal degradation through p38 activation. The current study provides new mechanistic link between NAR, cyclin D1 downregulation and cell growth in human colorectal cancer cells.
Keywords
Naringenin; Cyclin D1; Cancer chemoprevention; Human colorectal cancer;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Kawai, M., Hirano, T., Higa, S., Arimitsu, J., Maruta, M., Kuwahara, Y., Ohkawara, T., Hagihara, K., Yamadori, T., Shima, Y., Ogata, A., Kawase, I. and Tanaka, T. (2007) Flavonoids and related compounds as anti-allergic substances. Allergol. Int. 56, 113-123.   DOI
2 Kuo, S. M. (1997) Dietary flavonoid and cancer prevention: evidence and potential mechanism. Crit. Rev. Oncog. 8, 47-69.   DOI
3 Lee, C. H., Jeong, T. S., Choi, Y. K., Hyun, B. H., Oh, G. T., Kim, E. H., Kim, J. R., Han, J. I. and Bok, S. H. (2001) Anti-atherogenic effect of citrus flavonoids, naringin and naringenin, associated with hepatic ACAT and aortic VCAM-1 and MCP-1 in high cholesterol-fed rabbits. Biochem. Biophys. Res. Commun. 284, 681-688.   DOI
4 Mukhopadhyay, A., Banerjee, S., Stafford, L. J., Xia, C., Liu, M. and Aggarwal, B. B. (2002) Curcumin-induced suppression of cell proliferation correlates with down-regulation of cyclin D1 expression and CDK4-mediated retinoblastoma protein phosphorylation. Oncogene 21, 8852-8861.   DOI   ScienceOn
5 Okabe, H., Lee, S. H., Phuchareon, J., Albertson, D. G., McCormick, F. and Tetsu, O. (2006) A critical role for FBXW8 and MAPK in cyclin D1 degradation and cancer cell proliferation. PloS one 1, e128.   DOI
6 Ramos, S. (2007) Effects of dietary flavonoids on apoptotic pathways related to cancer chemoprevention. J. Nutr. Biochem. 18, 427-442.   DOI
7 Ravishankar, D., Rajora, A. K., Greco, F. and Osborn, H. M. (2013) Flavonoids as prospective compounds for anti-cancer therapy. Int J. Biochem. Cell Biol. 45, 2821-2831.   DOI
8 Renugadevi, J. and Prabu, S. M. (2010) Cadmium-induced hepatotoxicity in rats and the protective effect of naringenin. Exp. Toxicol. Pathol. 62, 171-181.   DOI
9 Siegel, R., Ma, J., Zou, Z. and Jemal, A. (2014) Cancer statistics, 2014. CA: Cancer J. Clin. 64, 364.   DOI
10 Spinella, M. J., Freemantle, S. J., Sekula, D., Chang, J. H., Christie, A. J. and Dmitrovsky, E. (1999) Retinoic acid promotes ubiquitination and proteolysis of cyclin D1 during induced tumor cell differentiation. J. Biol. Chem. 274, 22013-22018.   DOI
11 Tanaka, T. (2013) Role of apoptosis in the chemoprevention of cancer. J. Exp. Clin. Med. 5, 89-91.   DOI
12 Thoms, H. C., Dunlop, M. G. and Stark, L. A. (2007) p38-mediated inactivation of cyclin D1/cyclin-dependent kinase 4 stimulates nucleolar translocation of RelA and apoptosis in colorectal cancer cells. Cancer Res. 67, 1660-1669.   DOI
13 Totta, P., Acconcia, F., Leone, S., Cardillo, I. and Marino, M. (2004) Mechanisms of naringenin-induced apoptotic cascade in cancer cells: involvement of estrogen receptor alpha and beta signalling. IUBMB Life 56, 491-499.   DOI
14 van Acker, F. A., Schouten, O., Haenen, G. R., van der Vijgh, W. J. and Bast, A. (2000) Flavonoids can replace alpha-tocopherol as an antioxidant. FEBS Lett. 12, 145-148.
15 Wang, B. D., Yang, Z. Y., Wang, Q., Cai, T. K. and Crewdson, P. (2006) Synthesis, characterization, cytotoxic activities, and DNA-binding properties of the La(III) complex with Naringenin Schiff-base. Bioorg. Med. Chem. 14, 1880-1888.   DOI
16 Yoon, H., Kim, T. W., Shin, S. Y., Park, M. J., Yong, Y., Kim, D. W., Islam, T., Lee, Y. H., Jung, K. Y. and Lim, Y. (2013) Design, synthesis and inhibitory activities of naringenin derivatives on human colon cancer cells. Bioorg. Med. Chem. Lett. 23, 232-238.   DOI
17 Benzeno, S., Lu, F., Guo, M., Barbash, O., Zhang, F., Herman, J. G., Klein, P. S., Rustgi, A. and Diehl, J. A. (2006) Identification of mutations that disrupt phosphorylation-dependent nuclear export of cyclin D1. Oncogene 25, 6291-6303.   DOI
18 Alao, J. P. (2007) The regulation of cyclin D1 degradation: roles in cancer development and the potential for therapeutic invention. Mol. Cancer 6, 24.
19 Amaro, M. I., Helder Vila-Real, J. R., Eduardo-Figueira, M., Mota- Filipe, H., Sepodes, B. and Ribeiro, M. H. (2009) Anti-inflammatory activity of naringin and the biosynthesised naringenin by naringinase immobilized in microstructured materials in a model of DSS-induced colitis in mice. Food Res. Int. 42, 1010-1017.   DOI
20 Bahnassy, A. A., Zekri, A. R., El-Houssini, S., El-Shehaby, A. M., Mahmoud, M. R., Abdallah, S. and El-Serafi, M. (2004) Cyclin A and cyclin D1 as significant prognostic markers in colorectal cancer patients. BMC Gastroenterol. 4, 22.   DOI
21 Choi, J. S., Park, K. Y., Moon, S. H., Rhee, S. H. and Young, H. S. (1994) Antimutagenic effect of plant flavonoids in the Salmonella assay system. Arch. Pharm. Res. 17, 71-75.   DOI
22 Bulzomi, P., Bolli, A., Galluzzo, P., Acconcia, F., Ascenzi, P. and Marino, M. (2012) The naringenin-induced proapoptotic effect in breast cancer cell lines holds out against a high bisphenol a background. IUBMB Life 64, 690-696.   DOI
23 Casanovas, O., Miro, F., Estanyol, J.M., Itarte, E., Agell, N. and Bachs, O. (2000) Osmotic stress regulates the stability of cyclin D1 in a p38SAPK2-dependent manner. J. Biol. Chem. 275, 35091-35097.   DOI
24 Chidambara Murthy, K. N., Kim, J., Vikram, A. and Patil, B. S. (2012) Differential inhibition of human colon cancer cells by structurally similar flavonoids of citrus. Food Chem. 132, 27-34.   DOI
25 Cushnie, T. P. and Lamb, A. J. (2011) Recent advances in understanding the antibacterial properties of flavonoids. Int. J. Antimicrob. Agents 38, 99-107.   DOI
26 Diehl, J. A., Zindy, F. and Sherr, C. J. (1997) Inhibition of cyclin D1 phosphorylation on threonine-286 prevents its rapid degradation via the ubiquitin-proteasome pathway. Genes Dev. 11, 957-972.   DOI
27 Ekambaram, G., Rajendran, P., Magesh, V. and Sakthisekaran, D. (2008) Naringenin reduces tumor size and weight lost in N-methyl-N'-nitro-N-nitrosoguanidine-induced gastric carcinogenesis in rats. Nutr. Res. 28, 106-112.   DOI
28 Galluzzo, P., Ascenzi, P., Bulzomi, P. and Marino, M. (2008) The nutritional flavanone naringenin triggers antiestrogenic effects by regulating estrogen receptor alpha-palmitoylation. Endocrinology 149, 2567-2575.   DOI   ScienceOn
29 Huang, J. W., Shiau, C. W., Yang, Y. T., Kulp, S. K., Chen, K. F., Brueggemeier, R. W., Shapiro, C. L. and Chen, C. S. (2005) Peroxisome proliferator-activated receptor gamma-independent ablation of cyclin D1 by thiazolidinediones and their derivatives in breast cancer cells. Mol. Pharm. 67, 1342-1348.   DOI
30 Garcia-Lafuente, A., Guillamon, E., Villares, A., Rostagno, M. A. and Martinez, J. A. (2009) Flavonoids as anti-inflammatory agents: implications in cancer and cardiovascular disease. Inflamm. Res. 58, 537-552.   DOI
31 Imai, M., Kikuchi, H., Denda, T., Ohyama, K., Hirobe, C. and Toyoda, H. (2009) Cytotoxic effects of flavonoids against a human colon cancer derived cell line, COLO 201: a potential natural anti-cancer substance. Cancer Lett. 276, 74-80.   DOI
32 Kanno, S., Shouji, A., Asou, K. and Ishikawa, M. (2003) Effects of naringin on hydrogen peroxide-induced cytotoxicity and apoptosis in P388 cells. J. Pharmacol. Sci. 92, 166-170.   DOI
33 Kanno, S., Shouji, A., Hirata, R., Asou, K. and Ishikawa, M. (2004) Effects of naringin on cytosine arabinoside (Ara-C)-induced cytotoxicity and apoptosis in P388 cells. Life Sci. 75, 353-365.   DOI
34 Kanno, S., Tomizawa, A., Ohtake, T., Koiwai, K., Ujibe, M., Ishikawa, M. (2006) Naringenin-induced apoptosis via activation of NF-kappaB and necrosis involving the loss of ATP in human promyeloleukemia HL-60 cells. Toxicol Lett. 166, 131-139.   DOI
35 Kato, J., Matsushime, H., Hiebert, S. W., Ewen, M. E. and Sherr, C. J. (1993) Direct binding of cyclin D to the retinoblastoma gene product (pRb) and pRb phosphorylation by the cyclin D-dependent kinase CDK4. Genes Dev. 7, 331-342.   DOI